Powerpoint Presentation

27
The Synthesis of NPFF Receptor Ligand A dual-acting compound with opioid agonist & neuropeptide FF antagonist

Transcript of Powerpoint Presentation

Page 1: Powerpoint Presentation

The Synthesis of NPFF Receptor Ligand

A dual-acting compound with opioid agonist & neuropeptide FF

antagonist

Page 2: Powerpoint Presentation

Introduction

Caroline Morris

Hernando, MSUniversity of Mississippi

Undergraduate JuniorB.S in Pharmaceutical Sciences,

pursuing Pharm.D

Page 3: Powerpoint Presentation

Table of Contents1. Background

2. Projected Solution

3. Methodology

4. Conclusion

5. Personal Development

6. Acknowledgements

7. Questions

Page 4: Powerpoint Presentation

Background

• Chronic pain affects 116 million Americans per year 1

• Opioid drugs are the primary prescribed pain-killers

1O’Reilly, Kevin B. American Medical News. 2011

Page 5: Powerpoint Presentation

Background

• Opioid drugs have several side effects:- digestive problems2

- addiction3

- tolerance3

As the dosage increases, the side effects increase until the point that the side effects outweigh the benefits

2Chan, Lingtak-Neander. Nutrition Issues in Gastroenterology. 20083Stuckert, Jeffery. Psych Central. 2011

Page 6: Powerpoint Presentation

Projected Solution

• Previous research has discovered that the Neuropeptide FF antagonist receptors can prevent morphine-induced tolerance

• The use of a dual-acting compound with Opioid & NPFF receptors looks promising:

-opioid drug use without tolerance

Page 7: Powerpoint Presentation

Projected Solution

1. VBJ192 works- warm-water immersion test

Page 8: Powerpoint Presentation

Projected Solution

2. Blood-Brain Barrier

3. Structure-Activity Relationship (SAR)

Page 9: Powerpoint Presentation

Projected Solution

• Amidine functional groupcan penetrate the blood-brain barrier

• Similarities to VBJ192

Page 10: Powerpoint Presentation

Methodology

1. Synthesis of Benzyltriphenylphosphonium salt

A: 1 mole, B: 1 mole, C: 97% yield

A B C

Page 11: Powerpoint Presentation

Methodology

2. Wittig Reaction

A B

A: 34.62mmol, LDA: 38.06mmol, 1-benzylpiperidin-4-one: 6.7mL, B: 42.2% yield

Page 12: Powerpoint Presentation

Methodology

3. Bromination

A B

A: 5.58mmol, Br2: 8.37mmol, NaOH: 21.63mmol, B: 80.7% yield

Page 13: Powerpoint Presentation

Methodology

4. Suzuki Coupling

A B C

A: 5.23mmol, B: 6.28mmol, Pd(PPh3)4: 0.1205g, K2CO3: 13.09mmol, C: 52.1% yield

Page 14: Powerpoint Presentation

Methodology

5. Garigipati Reaction

A B

A: 0.275mmol, NH4Cl: 0.495mmol, Al(CH3)3: 0.458mmol, B: 56% yield

Page 15: Powerpoint Presentation

Methodology

1. Filtration 2. Column Chromatography

Page 16: Powerpoint Presentation

Methodology

• Because this synthesis required multiple steps, after each step, verification had to take place in before starting the next reaction

-in order to determine it was actually the desired product-make sure there were no impurities

Page 17: Powerpoint Presentation

Methodology

Thin Layer Chromatography (TLC)- used to determine Rf value

Rf value = distance product traveled distance solvent traveled = 6.25 cm

8.00 cm = 0.781

Page 18: Powerpoint Presentation

Methodology

TLC is also used to make comparisons:-the compound is the same across, verifying that the different tubes from column chromatography contain the same compound.

Page 19: Powerpoint Presentation

Methodology

-Bromination was successful! -Suzuki was successful!

Mass Spectrometry (MS)-verifies the mass of the compound

Page 20: Powerpoint Presentation

Conclusion

• We successfully modified VBJ192 into an amidine derivative• NMR verified

• Pharmacological evaluation will be performed on this compound

Page 21: Powerpoint Presentation

Personal Development

1. Honed research/lab skills2. Delved into Medicinal Chemistry3. Application of prior information4. Patience

Page 22: Powerpoint Presentation

Acknowledgements

Dr. Christopher McCurdyDr. Coco Kapanda

Kelsey LueckeDr. Velvet JourniganDr. Stephen Cutler

COBRE Grant P20GM104932

Page 23: Powerpoint Presentation

Questions

Page 24: Powerpoint Presentation

Wittig Mechanism

Page 25: Powerpoint Presentation

Bromination

Page 26: Powerpoint Presentation

Suzuki

Page 27: Powerpoint Presentation

Garigipati